Thiamine-responsive inborn errors of metabolism.

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disorders

Background:

• Thiamine (vitamin B1) plays a crucial role in metabolic pathways.
• Certain inherited metabolic disorders present challenges in treatment and management.
• Previous observations suggested potential therapeutic roles for thiamine in specific conditions.

Purpose of the Study:

• To evaluate the efficacy of thiamine supplementation in inherited disorders.
• To determine optimal dosage and treatment duration for thiamine therapy.
• To investigate the biochemical mechanisms underlying thiamine's effects.

Main Methods:

• Review of cases involving thiamine treatment for inherited disorders.
• Dosage ranging from 20 to 2400 mg/day was assessed.
• Concurrent therapies, like dietary modifications, were considered.

Main Results:

• Thiamine demonstrated beneficial effects in maple syrup urine disease (MSUD), lactic acidaemia, and a specific anemia syndrome.
• High doses of thiamine improved the stability of branched-chain ketoacid decarboxylase.
• Therapeutic effects were observed after several weeks of treatment.

Conclusions:

• Thiamine is a potential therapeutic agent for specific inherited metabolic disorders.
• Long-term, high-dose thiamine treatment warrants consideration.
• Further research into thiamine's role in metabolic disease is indicated.